Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2013-09-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Data Analysis of the Development of Hypernatremia in Intensive Care Unit
NCT03752450
Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients
NCT05085223
Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis
NCT01617798
Plasma Sodium and Sodium Administration in the ICU
NCT06037928
Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water
NCT06061783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hydrochloorthiazide
once a day 25 mg
Hydrochloorthiazide
placebo
once a day placebo
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrochloorthiazide
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Frisius Medisch Centrum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
E.C. Boerma
MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christiaan Boerma, MD
Role: PRINCIPAL_INVESTIGATOR
Frisius Medisch Centrum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Centre Leeuwarden
Leeuwarden, Provincie Friesland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABR 44878
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.